CARS2 (Mitochondrial Cysteinyl-tRNA Synthetase) is a nuclear-encoded gene that encodes a mitochondrial aminoacyl-tRNA synthetase (mtARS) essential for mitochondrial protein synthesis. Aminoacyl-tRNA synthetases (ARS) are essential enzymes that catalyze the attachment of specific amino acids to their corresponding transfer RNA (tRNA) molecules, forming aminoacyl-tRNA intermediates that are then used in ribosomal protein synthesis. CARS2 specifically charges cysteine to mitochondrial tRNA^Cys, enabling the translation of mitochondrial DNA-encoded proteins within the mitochondrial matrix. Mitochondria encode 13 essential components of the oxidative phosphorylation (OXPHOS) machinery, and proper mitochondrial translation is critical for cellular energy production. Mutations in CARS2 cause mitochondrial translation defects leading to combined oxidative phosphorylation deficiencies, characterized by variable involvement of multiple mitochondrial respiratory chain complexes. The resulting energy deficit particularly affects high-energy-demand tissues including brain, skeletal muscle, and heart, manifesting as mitochondrial encephalomyopathies, Leigh syndrome, leukoencephalopathy, and sensorineural hearing loss [1][2].
CARS2 belongs to the class II aminoacyl-tRNA synthetase family and exhibits the following catalytic properties:
tRNA Recognition: CARS2 specifically recognizes mitochondrial tRNA^Cys, which contains the characteristic anticodon sequence 5'-GCA-3' (read as cysteine codon). The enzyme distinguishes mitochondrial tRNA from cytoplasmic tRNA^Cys through unique structural features including the absence of base pairs in the D-arm and a longer variable loop [3].
Aminoacylation Reaction: The catalytic cycle proceeds through two-step aminoacylation:
Proofreading: Some mtARS enzymes possess editing capabilities to ensure fidelity. CARS2 may include editing functions to prevent mischarging of cysteine to non-cognate tRNAs.
The CARS2 enzyme is essential for mitochondrial translation for several reasons:
Cysteine Codons in Mitochondrial Genomes: The mitochondrial genetic code uses the codon AGA and AGG as stop codons (not arginine as in the nuclear code), and uses AUA for methionine (not isoleucine). However, cysteine is encoded by UGU and UGC codons, which require tRNA^Cys for translation.
Limited tRNA Complement: Mitochondria possess a minimal set of tRNAs (typically 22 tRNAs) that must decode all codons through "two-out-of-three" and "UAN" codon recognition. tRNA^Cys is essential for decoding cysteine codons in all mitochondrial genes.
Complex I Assembly: Multiple cysteine-containing subunits are part of NADH:ubiquinone oxidoreductase (Complex I), making CARS2 essential for Complex I biogenesis.
The CARS2 protein contains several functional domains:
CARS2 exhibits highest expression in tissues with high mitochondrial demand:
| Tissue | Expression Level |
|---|---|
| Brain (cerebral cortex) | Very High |
| Brain (cerebellum) | Very High |
| Brain (substantia nigra) | High |
| Heart (cardiac muscle) | Very High |
| Skeletal muscle | Very High |
| Liver | Moderate-High |
| Kidney | Moderate |
| Pancreas | Moderate |
| Lung | Low-Moderate |
CARS2 localizes exclusively to the mitochondrial matrix, where it:
CARS2 mutations cause variable phenotypes affecting multiple OXPHOS complexes:
Complex I Deficiency: Most common defect due to multiple Complex I subunits requiring cysteine residues. Manifests as:
Complex IV Deficiency: Cytochrome c oxidase deficiency is also common. Features include:
Multiple Complex Deficiencies: Severe cases show combined deficiency of Complexes I, III, IV, and V.
Leigh syndrome (subacute necrotizing encephalomyelopathy) is characterized by:
CARS2-related Leigh syndrome typically presents in early childhood with developmental delays followed by rapid neurological decline.
CARS2 mutations cause a distinctive pattern of white matter disease:
MRI Features:
Clinical Features:
Perrault syndrome is characterized by:
CARS2 mutations may cause this phenotype through mitochondrial dysfunction affecting inner ear hair cells and ovarian granulosa cells.
The broader category of mitochondrial encephalomyopathy encompasses:
The primary disease mechanism involves impaired mitochondrial translation leading to:
The ATP deficit particularly affects:
Mitochondrial dysfunction leads to:
Chronic energy failure can trigger:
| Partner | Interaction Type | Functional Role |
|---|---|---|
| Mitochondrial Ribosome | Direct binding | Translation machinery |
| Mitochondrial tRNA^Cys | Substrate | Aminoacylation |
| Mitochondrial DNA | Proximity | Translation coupling |
| ATP | Substrate | Catalytic energy |
| Other mtARS | Complex | Translation complex |
Several model systems have been used to study CARS2: